Filing Details
- Accession Number:
- 0000899243-19-030015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-23 21:07:09
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-23 21:07:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654909 | Jake Bauer | C/O Myokardia Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-20 | 10,000 | $9.08 | 54,998 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-20 | 7,500 | $13.90 | 62,498 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-20 | 18,916 | $70.07 | 43,582 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 10,000 | $0.00 | 10,000 | $9.08 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 7,500 | $0.00 | 7,500 | $13.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,748 | 2026-02-01 | No | 4 | M | Direct | |
| 0 | 2027-07-19 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $70.00 to $70.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2016, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- The shares subject to this option vested in two annual installments after July 20, 2017.
Billionaire Hedge Funds
